Showing results (241-250 of 309) with videos related to
Sort By:
Pageof 31
Leukemia|February 1, 1989
Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocolE Berman, Z A Arlin, J Gaynor, et al.Journal of Hematotherapy|January 1, 1993
Genetic therapy of human neoplastic diseaseA B Deisseroth, E G Hanania, S Fu, et al.Gene Therapy|June 1, 1995
Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance geneE G Hanania, S Fu, Z Zu, et al.Leukemia|October 1, 1996
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adultsS M Kornblau, V Gandhi, H M Andreeff, et al.Leukemia|August 22, 2003
Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAILW-S Suh, Y S Kim, A D Schimmer, et al.The Journal of Clinical Investigation|September 19, 2001
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemiaM Milella, S M Kornblau, Z Estrov, et al.Blood|April 1, 1980
Heterogeneity of cell lineages in L3 leukemiasB Koziner, R Mertelsmann, M Andreeff, et al.Blood|November 1, 1995
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.The New England Journal of Medicine|September 9, 1993
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantationS Giralt, S Escudier, H Kantarjian, et al.Blood|September 1, 1996
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytesJ Drach, A Gsur, G Hamilton, et al.Pageof 31